A Phase I/II Study of the Combination of Panobinostat and Carfilzomib in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Final Analysis of Second Dose Expansion
- Resource Type
- Abstract
- Source
- In
Blood 2 December 2016 128(22):4530-4530 - Subject
- Language
- ISSN
- 0006-4971